These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32124025)

  • 21. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.
    LoCasale RJ; Datto CJ; Margolis MK; Tack J; Coyne KS
    Int J Clin Pract; 2015 Dec; 69(12):1448-56. PubMed ID: 26344578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.
    Roeland EJ; Sera CJ; Ma JD
    Support Care Cancer; 2020 Apr; 28(4):1793-1797. PubMed ID: 31332514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laxative utilization over time in chronic pain patients with opioid-induced constipation.
    Datto CJ; LoCasale RJ; Margolis MK; Thompson CL; Coyne KS
    Pain Manag; 2016 Nov; 6(6):531-541. PubMed ID: 27476539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.
    Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Jpn J Clin Oncol; 2021 Mar; 51(3):444-450. PubMed ID: 33157554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience.
    Coyne KS; Currie BM; Holmes WC; Crawley JA
    Patient; 2015 Aug; 8(4):317-27. PubMed ID: 25231829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant Opioid and Laxative Use in Older Adults in Hospice Care in the United States: 2007.
    Lau DT; Dwyer LL; Shega JW
    J Am Geriatr Soc; 2016 Nov; 64(11):e160-e165. PubMed ID: 27642134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rethinking Docusate's Role in Opioid-Induced Constipation: A Critical Analysis of the Evidence.
    Engle AL; Winans ARM
    J Pain Palliat Care Pharmacother; 2021 Mar; 35(1):63-72. PubMed ID: 33596159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid induced constipation management in orthopaedic and trauma patients: treatment and the potential of nurse-initiated management.
    Sonneborn O; Bui T
    Int J Orthop Trauma Nurs; 2019 Aug; 34():16-20. PubMed ID: 31126838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain.
    Patel J; Lucas CJ; Margalit M; Martin JH
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):116-123. PubMed ID: 30735070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inpatient use of laxatives during opioid administration in children with sickle cell disease.
    O'Brien SH; Fan L; Kelleher KJ
    Pediatr Blood Cancer; 2010 Apr; 54(4):559-62. PubMed ID: 20049931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information on risk of constipation for Danish users of opioids, and their laxative use.
    Pottegård A; Knudsen TB; van Heesch K; Salmasi H; Schytte-Hansen S; Søndergaard J
    Int J Clin Pharm; 2014 Apr; 36(2):291-4. PubMed ID: 24562974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare resource use and costs of opioid-induced constipation among non-cancer and cancer patients on opioid therapy: A nationwide register-based cohort study in Denmark.
    Søndergaard J; Christensen HN; Ibsen R; Jarbøl DE; Kjellberg J
    Scand J Pain; 2017 Apr; 15():83-90. PubMed ID: 28850356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
    Harada T; Imai H; Fumita S; Noriyuki T; Gamoh M; Okamoto M; Akashi Y; Kizawa Y; Tokoro A
    Int J Clin Oncol; 2021 Jan; 26(1):104-110. PubMed ID: 33068220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
    Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
    Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Nationwide Hospital Claims Database Analysis of Real-World Patterns of Laxative Use for Opioid-Induced Constipation in Japanese Patients with Cancer.
    Higashibata T; Kessoku T; Morioka Y; Koretaka Y; Mishima H; Shibahara H; Masuda Y; Ichikawa Y; Nakajima A; Hisanaga T
    Pain Ther; 2023 Aug; 12(4):993-1003. PubMed ID: 37195398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Survey of Prophylactic Administration of Naldemedine for Opioid-induced Constipation].
    Ozawa Y; Haruki Y; Ohata M; Isono H; Takahashi M; Tate A; Ukita S; Hayashi S
    Yakugaku Zasshi; 2023; 143(2):183-189. PubMed ID: 36724931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.